Heuser C, Renner K, Kreutz M, Gattinoni L
Research is exploring whether GLP-3 might offer cardiovascular protection through mechanisms distinct from GLP-1, complement GLP-1s cardiovascular benefits, have unique effects on heart metabolism or function, and provide benefits in cardiovascular conditions where metabolic dysfunction plays a role
No media logos, no third-party award claims, and no testing or partnership claims that need backing up
We also observed a reduction in IL-6 expression and an increase in IL-8 expression after FOXO4-DRI treatment
Other Ingredients : Natural French Vanilla Flavor Contraindications : The components of whey include lactoferrin, beta-lactoglobulin, alpha lactalbumin, glycomacropeptide, and immunoglobulins